WO1982002890A1 - Cyclodextrin clathrate compounds of sulfur-containing compounds - Google Patents
Cyclodextrin clathrate compounds of sulfur-containing compounds Download PDFInfo
- Publication number
- WO1982002890A1 WO1982002890A1 PCT/JP1982/000050 JP8200050W WO8202890A1 WO 1982002890 A1 WO1982002890 A1 WO 1982002890A1 JP 8200050 W JP8200050 W JP 8200050W WO 8202890 A1 WO8202890 A1 WO 8202890A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- lower alkyl
- compound
- phenyl
- substituted
- general formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
- C07C319/20—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
- C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
Definitions
- a Le key Le group of the showing the 2 H is, o having 1 to 6 carbon atoms The same shall apply hereinafter o)
- the compound represented by the general formula [I] is a known compound and is known to have various actions such as antihypertensive action, anti-rheumatic action, liver disease inhibitory action, and sputum dissolution action.
- the water-miscible organic solvents used in the present invention include methanol, ethanol, and n-fluoro. ⁇ , , , , , ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ Adjust appropriately depending on the solubility of the product o
- Example 1 The compounds of Example 1 and Compound II were subjected to storage experiments in water and phosphate buffered saline (pH 7.0) at room temperature for one month, and the compound of Example 1 was higher than that of Compound A. It was quite stable o '
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nanotechnology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Materials Engineering (AREA)
- Veterinary Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Crystallography & Structural Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE823233697T DE3233697T1 (de) | 1981-02-28 | 1982-02-24 | Einschlussverbindungen von cyclodextrin mit schwefel enthaltenden verbindungen |
NL8220038A NL8220038A (nl) | 1981-02-28 | 1982-02-24 | Insluitverbindingen van cyclodextrine met zwavelhoudende verbindingen. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56029060A JPS57142962A (en) | 1981-02-28 | 1981-02-28 | Cyclodextrin clathrate compound of sulfur-containing compound |
JP81/29060810228 | 1981-02-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1982002890A1 true WO1982002890A1 (en) | 1982-09-02 |
Family
ID=12265815
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1982/000050 WO1982002890A1 (en) | 1981-02-28 | 1982-02-24 | Cyclodextrin clathrate compounds of sulfur-containing compounds |
Country Status (10)
Country | Link |
---|---|
US (1) | US4482709A (ja) |
EP (1) | EP0072868B1 (ja) |
JP (1) | JPS57142962A (ja) |
KR (1) | KR830009064A (ja) |
DE (1) | DE3233697T1 (ja) |
ES (1) | ES8302783A1 (ja) |
GB (1) | GB2106917A (ja) |
IT (1) | IT1150200B (ja) |
NL (1) | NL8220038A (ja) |
WO (1) | WO1982002890A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2518542A1 (fr) * | 1981-12-23 | 1983-06-24 | Maggioni Farma | Dipeptides comportant un residu methionine et ayant un effet de protection pour le foie |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2138813B (en) * | 1983-04-25 | 1987-02-04 | Squibb & Sons Inc | Proline derivatives |
JPS6025967A (ja) * | 1983-07-21 | 1985-02-08 | Eisai Co Ltd | トリパミド包接化合物 |
JPS6081166A (ja) * | 1983-10-11 | 1985-05-09 | Fujisawa Pharmaceut Co Ltd | 2−ニトロオキシメチル−6−クロロピリジンのβ−シクロデキストリン包接化合物およびその製造法 |
JPS60152535A (ja) * | 1984-01-20 | 1985-08-10 | Ichiro Shibauchi | 架橋剤及びその製造方法 |
HU193933B (en) * | 1984-06-08 | 1987-12-28 | Nitrokemia Ipartelepek | Herbicide or plant growth stimulating agent comprising beta-cyclodextrin complex of benzolsulphonylurea derivative and process for preparing the active substances |
US4883785A (en) * | 1984-07-27 | 1989-11-28 | Chow Wing Sun | Complex of anti-fungal agent and cyclodextrin and method |
US4636522A (en) * | 1985-03-22 | 1987-01-13 | E. R. Squibb & Sons, Inc. | Acylaminoalkanoyl urethanes or thiourethanes |
KR870007114A (ko) * | 1986-01-21 | 1987-08-14 | 우에노 기미오 | 티올 에스테르 유도체의 안정된 고형제 |
US5179125A (en) * | 1987-12-03 | 1993-01-12 | Dainippon Pharmaceutical Co., Ltd. | N-substituted mercaptopropanamide derivatives |
EP0318859A3 (en) * | 1987-12-03 | 1990-08-16 | Dainippon Pharmaceutical Co., Ltd. | N-substituted mercaptopropanamide derivatives |
US5210266A (en) * | 1987-12-03 | 1993-05-11 | Dainippon Pharmaceutical Co., Ltd. | N-substituted mercaptopropanamide derivatives |
FR2651229B1 (fr) * | 1989-08-24 | 1991-12-13 | Inst Nat Sante Rech Med | Nouveaux derives d'amino-acides, leur procede de preparation et leur application therapeutique. |
US5064944A (en) * | 1989-09-12 | 1991-11-12 | Advanced Separation Technologies Inc. | Chiral separation media |
US4948395A (en) * | 1989-09-12 | 1990-08-14 | Advanced Separations Technologies Inc. | Chiral separation media |
US5154738A (en) * | 1989-09-12 | 1992-10-13 | Advanced Separation Technologies, Inc. | Chiral separation media |
US6025393A (en) * | 1995-09-25 | 2000-02-15 | Santen Pharmaceutical Co., Ltd. | Method for treatment of inflammatory intestinal diseases |
ES2118673T3 (es) * | 1996-10-29 | 2001-04-16 | Staroil Ltd | Composiciones solubles en la boca que contienen n-acetilcisteina y ciclodextrina. |
FR2912061A1 (fr) * | 2007-02-01 | 2008-08-08 | Aliscience Soc Par Actions Sim | Complexes d'inclusion de cysteine, leur presparation et les compositions les contenant |
CN113088699B (zh) * | 2021-03-31 | 2022-04-05 | 南昌航空大学 | 一种废弃线路板酸浸液中金的吸附还原回收和强酸回用的方法 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5089516A (ja) * | 1973-12-14 | 1975-07-18 | ||
JPS5094108A (ja) * | 1973-12-20 | 1975-07-26 | ||
JPS50116617A (ja) * | 1974-02-25 | 1975-09-12 | ||
JPS52136117A (en) * | 1976-05-10 | 1977-11-14 | Squibb & Sons Inc | Compound useful as depressor for angiotensin transforming enzyme and its method of manufacturing |
JPS545916A (en) * | 1977-06-17 | 1979-01-17 | Santen Pharmaceutical Co Ltd | Novel cystein derivative |
JPS5618953A (en) * | 1979-07-13 | 1981-02-23 | Usv Pharma Corp | Antihypertensive amides |
JPS5726656A (en) * | 1980-06-09 | 1982-02-12 | Morton Norwich Products Inc | N-(cycloalkyl)amino acid compound |
JPS5732260A (en) * | 1980-08-07 | 1982-02-20 | Meito Sangyo Kk | Mercaptofatty acid derivative and its preparation |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US435618A (en) * | 1890-09-02 | Gustavus a | ||
CH451186A (de) * | 1961-11-02 | 1968-05-15 | Santen Phamarceutical Co Ltd | Verfahren zur Herstellung von N-Mercaptopropionylglycin und dessen Derivaten |
US4046889A (en) * | 1976-02-13 | 1977-09-06 | E. R. Squibb & Sons, Inc. | Azetidine-2-carboxylic acid derivatives |
JPS535112A (en) * | 1976-03-08 | 1978-01-18 | Santen Pharmaceutical Co Ltd | New cysteine derivatives |
US4430344A (en) * | 1978-04-08 | 1984-02-07 | Santen Pharmaceutical Co., Ltd. | Antihypertensive 4-thiazolidinecarboxylic acids |
JPS584711B2 (ja) * | 1978-08-02 | 1983-01-27 | 参天製薬株式会社 | ピロリジン誘導体 |
JPS6011888B2 (ja) * | 1978-10-11 | 1985-03-28 | 参天製薬株式会社 | リウマチ疾患治療薬 |
US4347371A (en) * | 1978-12-30 | 1982-08-31 | Santen Pharmaceutical Co., Ltd. | Disulfide compounds |
-
1981
- 1981-02-28 JP JP56029060A patent/JPS57142962A/ja active Granted
-
1982
- 1982-02-24 WO PCT/JP1982/000050 patent/WO1982002890A1/ja active IP Right Grant
- 1982-02-24 GB GB08229670A patent/GB2106917A/en not_active Withdrawn
- 1982-02-24 DE DE823233697T patent/DE3233697T1/de active Granted
- 1982-02-24 US US06/432,929 patent/US4482709A/en not_active Expired - Fee Related
- 1982-02-24 EP EP82900570A patent/EP0072868B1/en not_active Expired
- 1982-02-24 NL NL8220038A patent/NL8220038A/nl not_active Application Discontinuation
- 1982-02-24 IT IT19838/82A patent/IT1150200B/it active
- 1982-02-25 ES ES509911A patent/ES8302783A1/es not_active Expired
- 1982-02-26 KR KR1019820000846A patent/KR830009064A/ko unknown
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5089516A (ja) * | 1973-12-14 | 1975-07-18 | ||
JPS5094108A (ja) * | 1973-12-20 | 1975-07-26 | ||
JPS50116617A (ja) * | 1974-02-25 | 1975-09-12 | ||
JPS52136117A (en) * | 1976-05-10 | 1977-11-14 | Squibb & Sons Inc | Compound useful as depressor for angiotensin transforming enzyme and its method of manufacturing |
JPS545916A (en) * | 1977-06-17 | 1979-01-17 | Santen Pharmaceutical Co Ltd | Novel cystein derivative |
JPS5618953A (en) * | 1979-07-13 | 1981-02-23 | Usv Pharma Corp | Antihypertensive amides |
JPS5726656A (en) * | 1980-06-09 | 1982-02-12 | Morton Norwich Products Inc | N-(cycloalkyl)amino acid compound |
JPS5732260A (en) * | 1980-08-07 | 1982-02-20 | Meito Sangyo Kk | Mercaptofatty acid derivative and its preparation |
Non-Patent Citations (1)
Title |
---|
M.L. BENDER, M. KOMIYAMA "Cyclodextrin no Kagaku", 15. April. 1979 (15.04.79), Gakkai Shuppan Center (Tokyo), p. 55 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2518542A1 (fr) * | 1981-12-23 | 1983-06-24 | Maggioni Farma | Dipeptides comportant un residu methionine et ayant un effet de protection pour le foie |
Also Published As
Publication number | Publication date |
---|---|
EP0072868B1 (en) | 1985-07-24 |
IT8219838A0 (it) | 1982-02-24 |
IT1150200B (it) | 1986-12-10 |
ES509911A0 (es) | 1983-01-16 |
NL8220038A (nl) | 1983-01-03 |
JPS6217994B2 (ja) | 1987-04-21 |
DE3233697C2 (ja) | 1989-01-19 |
US4482709A (en) | 1984-11-13 |
DE3233697T1 (de) | 1983-03-24 |
GB2106917A (en) | 1983-04-20 |
KR830009064A (ko) | 1983-12-17 |
EP0072868A4 (en) | 1983-07-04 |
EP0072868A1 (en) | 1983-03-02 |
ES8302783A1 (es) | 1983-01-16 |
JPS57142962A (en) | 1982-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1982002890A1 (en) | Cyclodextrin clathrate compounds of sulfur-containing compounds | |
PE20000265A1 (es) | Composiciones que contienen virus y metodos para concentrar preparados de virus | |
KR830010121A (ko) | 세팔로스포린 유도체의 제조방법 | |
RU92004362A (ru) | Производные таксола и водорастворимые производные таксола | |
JPH0834746B2 (ja) | インク組成物 | |
IE45225B1 (en) | New dicarboxylic acid bis-(3,5-dicarboamoyl-2,4,6-triiodoanilides) | |
JPH1129593A (ja) | アミノ基を含む分子とキレート化剤の結合方法 | |
Klotz et al. | The binding of organic ions by proteins. Effects of changes in solvent and their implications as to the nature of the complexes | |
JPS60208998A (ja) | ヌクレオチドおよびポリヌクレオチドを非水性溶媒および非水性/水性混合溶媒系に溶解する方法 | |
DK0478732T3 (da) | Inklusionskomplekser af 3-morpholino-sydnonimin eller saltene deraf eller dens tautomerisomer, fremgangsmåde til fremstilli | |
JPS6075432A (ja) | ネオカルチノスタチン誘導体及びその製造方法 | |
JPS5912119B2 (ja) | アミノ酸誘導体の製造方法 | |
JPH07233147A (ja) | 精製l−ヒドロキシプロリンの製造法 | |
JPS5892647A (ja) | アゾイミノエ−テル塩酸塩およびその製造方法 | |
CN111100063B (zh) | 一种合成2-氟甲基取代的吡咯烷、哌啶以及哌嗪衍生物的制备方法 | |
JPS6011435A (ja) | フルオレノ−ル誘導体−アルコ−ル錯体およびこれを用いたアルコ−ルの分離方法 | |
JPS6011436A (ja) | ハイドロキノン誘導体−アルコ−ル錯体およびこれを用いたアルコ−ルの分離方法 | |
JPS61103897A (ja) | 抗カルパインの製造法 | |
JP3175253B2 (ja) | 単環式含窒素複素環化合物をゲストとする新規包接化合物 | |
WO1982003175A1 (en) | Water-soluble cholesterol derivatives | |
JP3178807B2 (ja) | 新規色素前駆体、新規色素、及びそれらの製造方法 | |
JPH02131495A (ja) | 抗レトロウィルス作用物質 | |
JPH10158235A (ja) | 4,4’−ジヒドロキシジフェニルスルホンモノエーテル誘導体の精製法 | |
WO2022262736A1 (zh) | 苯并恶嗪酮类衍生物 | |
JPS58185622A (ja) | 非感作性ポリオキシエチレンアルキルエ−テル酢酸塩及びその製造法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Designated state(s): AT CH DE GB NL US |
|
AL | Designated countries for regional patents |
Designated state(s): FR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1982900570 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1982900570 Country of ref document: EP |
|
RET | De translation (de og part 6b) |
Ref document number: 3233697 Country of ref document: DE Date of ref document: 19830324 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 3233697 Country of ref document: DE |
|
WWG | Wipo information: grant in national office |
Ref document number: 1982900570 Country of ref document: EP |